Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension.
Sharma A, Bagchi A, Kinagi SB, Sharma YK, Baliga VP, Bollmall C. Sharma A, et al. Clin Ther. 2007 Dec;29(12):2667-76. doi: 10.1016/j.clinthera.2007.12.017. Clin Ther. 2007. PMID: 18201582 Clinical Trial.
Amtolmetin: A Reappraisal of NSAID with Gastroprotection.
Garg A, Shoeb A, Moodahadu LS, Sharma A, Gandhi A, Akku S. Garg A, et al. Arthritis. 2016;2016:7103705. doi: 10.1155/2016/7103705. Epub 2016 Mar 22. Arthritis. 2016. PMID: 27092274 Free PMC article.
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin.
Jain A, Vispute A, Dange A, Naskar A, Mondal A, Vivekanand B, Sharma B, Varade D, Shukla D, Bhatia G, Chaudhari H, Ram Babu K, Gavali O, Sorate S, Bhanushali S, Kothari V, Khandelwal V, Sharma A, Pawar R, Mayabhate M, Shahavi V, Rajput A, Jaiswal M. Jain A, et al. Diabetes Ther. 2024 Jan;15(1):215-227. doi: 10.1007/s13300-023-01504-3. Epub 2023 Nov 14. Diabetes Ther. 2024. PMID: 37957465 Free PMC article.
Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.
Aashish M, Arindam N, Siddiqi SS, Bhosle D, Mallikarjuna VJ, Amol D, Sanket S, Omkar G, Parth P, Dhruvi H, Durga P, Pradeep D, Suresh K, Vaishali P, Mayura C, Indraneel B, Jayashri S, Arif F, Raghavendra SK, Deepak V, Ravindra T, Shaishav B, Vijay G, Khan K, Mahajani VV, Sharma AD, Mayabhate M, Pawar RR, Aiwale AS, Vinayaka S. Aashish M, et al. Among authors: sharma ad. Clin Diabetes Endocrinol. 2024 Feb 10;10(1):3. doi: 10.1186/s40842-023-00161-6. Clin Diabetes Endocrinol. 2024. PMID: 38336931 Free PMC article.
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.
Gupta PK, Maheshwari S, Cherian JJ, Goni V, Sharma AK, Tripathy SK, Talari K, Pandey V, Sancheti PK, Singh S, Bandyopadhyay S, Shetty N, Kamath SU, Prahaldbhai PS, Abraham J, Kannan S, Bhat S, Parshuram S, Shahavi V, Sharma A, Verma NN, Kumar U. Gupta PK, et al. Am J Sports Med. 2023 Jul;51(9):2254-2266. doi: 10.1177/03635465231180323. Epub 2023 Jun 27. Am J Sports Med. 2023. PMID: 37366164 Clinical Trial.
247 results